Insiders Harrow, Inc.

Equities

Market Closed - OTC Markets Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
20.89 ^USD	-0.52%		-0.52%	+86.52%

06-24	Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index	CI
06-21	Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained	MT

Harrow Names Greg Dipasquale as Senior Vice President, Head of Commercial	05-13	CI
Harrow, Inc. Announces Board of Director Appointments	01-29	CI
Harrow, Inc. Appoints John P. Saharek as President and Chief Executive Officer of its ImprimisRx Division	01-03	CI
Harrow, Inc. Announces Board and Committee Changes	11-03	CI
Insider Buy: Harrow Health	23-08-15	MT
Harrow Health, Inc. Announces Appointment of Mark Mannebach as Head of Regulatory Affairs and Pharmacovigilance	23-03-06	CI
Insider Buy: Harrow Health	22-12-23	MT
Insider Buy: Harrow Health	22-12-23	MT
Insider Sell: Harrow Health	22-10-04	MT
Akari Therapeutics Names Melissa Bradford-Klug COO	22-06-13	MT
Harrow Health, Inc. Announces Management Changes	22-03-31	CI
Harrow Health, Inc Announces Board Changes	21-08-23	CI
Insider Trends: Insider Purchase of Harrow Health Stock Continues 90-Day Positive Trend	21-08-19	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	21-07-22	MT
Insider Trends: Insider Purchase of Harrow Health Stock Extends 90-Day Positive Trend	21-06-22	MT
Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at Harrow Health	21-05-21	MT
Insider Trends: Harrow Health Insider 90-Day Buying Trend Prolonged with Purchase	20-12-22	MT
Harrow Health Appoints Larry Van Horn to its Board of Directors	20-09-30	CI
Harrow Health, Inc. Announces Board and Committee Changes	20-03-17	CI
Harrow Health, Inc. Announces Launch of Mayfield Pharmaceuticals; to Appoint Melissa Bradford-Klug to Lead Mayfield Pharmaceuticals, Inc	19-07-31	CI

No results for this search